Hans E. Hohmeier

3.1k citations

36 papers · 2.4k indexed · 1 hit paper · h-index 25

Surgery top 2%
Molecular Biology top 10%
Genetics top 2%
Endocrinology, Diabetes and Metabolism top 2%
Cell Biology top 5%

Co-authors: Christopher B. Newgard Hindrik Mulder Marc Prentki Veronique V. Tran Danhong Lu Patrick T. Fueger Samuel B. Stephens Jonathan C. Schisler
Topics: Pancreatic function and diabetes (33 papers)Diabetes and associated disorders (18 papers)Metabolism, Diabetes, and Cancer (8 papers)
Cited by: Surgery Endocrinology, Diabetes and Metabolism Genetics
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States Czechia United Kingdom

In The Last Decade

Hans E. Hohmeier

36 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.

2000 760 citations Hans E. Hohmeier, Hindrik Mulder et al. Diabetes profile →

Peers

Countries citing papers authored by Hans E. Hohmeier

Since Specialization

Citations

This map shows the geographic impact of Hans E. Hohmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans E. Hohmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans E. Hohmeier more than expected).

Fields of papers citing papers by Hans E. Hohmeier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans E. Hohmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans E. Hohmeier. The network helps show where Hans E. Hohmeier may publish in the future.

Co-authorship network of co-authors of Hans E. Hohmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Hans E. Hohmeier. A scholar is included among the top collaborators of Hans E. Hohmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans E. Hohmeier. Hans E. Hohmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of a small molecule that stimulates human β-cell proliferation and insulin secretion, and protects against cytotoxic stress in rat insulinoma cells 2020 ·PLoS ONE ·Hans E. Hohmeier,Lu Zhang,Brandon L. Taylor,Samuel B. Stephens,Danhong Lu,Peter McNamara,Bryan Laffitte,Christopher B. Newgard	19
2	Delayed apoptosis allows islet β-cells to implement an autophagic mechanism to promote cell survival 2017 ·PLoS ONE ·(unknown),Brett S. Peterson,Jonathan M. Haldeman,Christopher B. Newgard,Hans E. Hohmeier,Samuel B. Stephens	35
3	A Pdx-1-Regulated Soluble Factor Activates Rat and Human Islet Cell Proliferation 2016 ·Molecular and Cellular Biology ·(unknown),Lu Zhang,Thomas Becker,Jonathan M. Haldeman,Samuel B. Stephens,Michelle Arlotto,Larry G. Moss,Christopher B. Newgard,Hans E. Hohmeier	18
4	Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency 2015 ·Journal of Clinical Investigation ·Damaris N. Lorenzo,Jane Healy,Janell Hostettler,Jonathan R. Davis,Jiayu Yang,Chao Wang,Hans E. Hohmeier,Mingjie Zhang,Vann Bennett	15
5	Nkx6.1 regulates islet β-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors 2014 ·Proceedings of the National Academy of Sciences ·Jeffery S. Tessem,Larry G. Moss,Lily C. Chao,Michelle Arlotto,Danhong Lu,Mette V. Jensen,Samuel B. Stephens,Peter Tontonoz,Hans E. Hohmeier,Christopher B. Newgard	76
6	Control of Voltage-gated Potassium Channel Kv2.2 Expression by Pyruvate-Isocitrate Cycling Regulates Glucose-stimulated Insulin Secretion 2013 ·Journal of Biological Chemistry ·Mette V. Jensen,Jonathan M. Haldeman,Hengtao Zhang,Danhong Lu,Mark O. Huising,Wylie Vale,Hans E. Hohmeier,Paul B. Rosenberg,Christopher B. Newgard	18
7	The Role of Voltage-Gated Potassium Channels Kv2.1 and Kv2.2 in the Regulation of Insulin and Somatostatin Release from Pancreatic Islets 2012 ·Journal of Pharmacology and Experimental Therapeutics ·Xiaoyan Li,James Herrington,Aleksandr Petrov,Lan Ge,George J. Eiermann,Yusheng Xiong,Mette V. Jensen,Hans E. Hohmeier,Christopher B. Newgard,María L. García,Michael Wagner,Bei B. Zhang,Nancy A. Thornberry,Andrew D. Howard,Gregory J. Kaczorowski,Yun-Ping Zhou	60
8	A VGF-Derived Peptide Attenuates Development of Type 2 Diabetes via Enhancement of Islet β-Cell Survival and Function 2012 ·Cell Metabolism ·Samuel B. Stephens,Jonathan C. Schisler,Hans E. Hohmeier,Jie An,Albert Y. Sun,Geoffrey S. Pitt,Christopher B. Newgard	73
9	Ubiquitin Fold Modifier 1 (UFM1) and Its Target UFBP1 Protect Pancreatic Beta Cells from ER Stress-Induced Apoptosis 2011 ·PLoS ONE ·Katleen Lemaire,Rodrigo Ferreira de Moura,Mikaela Granvik,Mariana Igoillo‐Esteve,Hans E. Hohmeier,Nico Hendrickx,Christopher B. Newgard,Etienne Waelkens,Miriam Cnop,Frans Schuit	156
10	Cholinergic Augmentation of Insulin Release Requires Ankyrin-B 2010 ·Science Signaling ·Jane Healy,Kent R. Nilsson,Hans E. Hohmeier,Jelena P. Berglund,Jonathan R. Davis,(unknown),Martin Köhler,(unknown),Per‐Olof Berggren,Christopher B. Newgard,Vann Bennett	31
11	Agenesis of the Dorsal Pancreas and Associated Diseases 2008 ·Digestive Diseases and Sciences ·W. Schnedl,(unknown),(unknown),Pia Reittner,Robert Krause,Rainer W. Lipp,Hans E. Hohmeier	51
12	Silencing of Cytosolic or Mitochondrial Isoforms of Malic Enzyme Has No Effect on Glucose-stimulated Insulin Secretion from Rodent Islets 2008 ·Journal of Biological Chemistry ·Sarah M. Ronnebaum,Mette V. Jensen,Hans E. Hohmeier,Shawn C. Burgess,(unknown),Su Qian,Douglas J. MacNeil,Andrew Howard,Nancy A. Thornberry,Olga Ilkayeva,Danhong Lu,A. Dean Sherry,Christopher B. Newgard	63
13	Enhanced cAMP Protein Kinase A Signaling Determines Improved Insulin Secretion in a Clonal Insulin-Producing β-Cell Line (INS-1 832/13) 2004 ·Molecular Endocrinology ·Shumin Yang,(unknown),(unknown),Lena Stenson Holst,Hans E. Hohmeier,Erik Renström,Hindrik Mulder	22
14	Cell lines derived from pancreatic islets 2004 ·Molecular and Cellular Endocrinology ·Hans E. Hohmeier,Christopher B. Newgard	101
15	Understanding of basic mechanisms of β-cell function and survival 2004 ·Cell Biochemistry and Biophysics ·Christopher B. Newgard,Hans E. Hohmeier,Danhong Lu,Mette V. Jensen,Veronique V. Tran,Guoxun Chen,Shawn C. Burgess,A. Dean Sherry	3
16	Inflammatory mechanisms in diabetes: lessons from the β-cell 2003 ·International Journal of Obesity ·Hans E. Hohmeier,Veronique V. Tran,(unknown),Rosa Gasa,Christopher B. Newgard	58
17	Expression of the Transcription Factor STAT-1α in Insulinoma Cells Protects against Cytotoxic Effects of Multiple Cytokines 2001 ·Journal of Biological Chemistry ·Guoxun Chen,Hans E. Hohmeier,Christopher B. Newgard	27
18	Selection of insulinoma cell lines with resistance to interleukin-1beta- and gamma-interferon-induced cytotoxicity. 2000 ·Diabetes ·(unknown),Hans E. Hohmeier,Rosa Gasa,Veronique V. Tran,(unknown)	56
19	Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1beta- induced cytotoxicity and reduces nitric oxide production. 1998 ·Journal of Clinical Investigation ·Hans E. Hohmeier,Anice E. Thigpen,Veronique V. Tran,Randall L. Davis,Christopher B. Newgard	129
20	Engineered cell lines for insulin replacement in diabetes: current status and future prospects 1997 ·Diabetologia ·Christopher B. Newgard,Sam Clark,Hector BeltrandelRio,Hans E. Hohmeier,C Quaade,Karl Normington	51

About Hans E. Hohmeier

Hans E. Hohmeier is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics, having authored 36 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (33 papers), Diabetes and associated disorders (18 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Surgery (1.6k citations), Endocrinology, Diabetes and Metabolism (576 citations) and Genetics (745 citations). Hans E. Hohmeier has collaborated with scholars based in United States, Czechia and United Kingdom. Frequent co-authors include Christopher B. Newgard, Hindrik Mulder, Marc Prentki, Veronique V. Tran, Danhong Lu, Patrick T. Fueger, Samuel B. Stephens, Jonathan C. Schisler, Randall L. Davis and Anice E. Thigpen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact